The MSH2 gene is commonly changed in PCa by deletion, missense, and frameshift mutations that also cause the buildup of neoantigens, raise the burden of tumor mutations, and increase the density of lymphocytes that infiltrate tumors (Haraldsdottir et al., 2014; Dominguez-Valentin et al., 2016). Here, MSH2 is linked to neoplasm.